Brain Cancer | Tumor

The CURE® clinical focus center for brain cancer covers both brain cancers as well as brain metastases and the ongoing research for treating these malignancies.

Online Resources for Patients with Metastatic Brain Tumors

February 3rd 2021, 11:00am


The American Brain Tumor Association offers a wealth of online resources for patients with metastatic brain tumors and their loved ones and caregivers.

Management of Cancer That Has Spread to the Brain

December 23rd 2020, 5:00am


Study Shows No Further Improvement in Prognosis of Patients with Recurrent High-Grade Glioma

December 22nd 2020, 2:00pm


Researchers try new drug combination to improve overall survival in patients with recurrent high-grade glioma, but are unsuccessful.

FDA Approves Investigational New Drug Application of Novel Therapy for Brain Cancer, Allowing the Treatment to Be Studied in Humans

December 21st 2020, 11:00pm


The approval of an investigational new drug application will allow Berubicin’s manufacturer to begin studying the investigational drug in adults with glioblastoma who have previously failed their first treatment.

How Joe Biden’s Experience With Cancer Influenced My Journey

December 10th 2020, 5:30pm


President-elect has a well known personal relationship with cancer as his son Beau Biden was diagnosed with glioblastoma and passed from this disease. This high-profile journey and story had an impact on my own journey with cancer.

Friday Frontline: NCI Research Project Identifies Genomic Mutations That Helped “Exceptional Responders”, a 15-Year-Old Cancer Survivor Dies of COVID-19, And More

November 27th 2020, 4:00pm


From the National Cancer Institute releasing promising research data into the genomic mutations that helped “exceptional responders” survive on treatment when others didn’t, to a 15-year-old Kentucky cancer survivor dying from COVID-19, here’s what’s happening in the cancer landscape this week.

FDA Accelerates Approval of Danyelza for Children and Adults with Relapsed or Refractory High-Risk Neuroblastoma

November 25th 2020, 11:13pm


The Food and Drug Administration’s approval of Danyelza comes as a result of two trials that assessed the efficacy of the drug in patients with relapsed or refractory high-risk neuroblastoma in the bone or bone marrow who did not have sufficient response to prior therapies.

What it Was Like to Lose My Niece to Cancer

September 20th 2020, 6:00pm


The call that raised the hair on my arms, which is the one I least expected, came at 7:30 a.m. during a sales meeting.

There are No ‘Right’ Answers When it Comes to Cancer

September 16th 2020, 4:00pm


As a caregiver, you rarely have 10 seconds to think or reflect on anything, but with my husband gone now, I find myself looking back more than ever. There are so many things we did right, and so many things I’ll probably always feel unsure of.

Laughing In The Face of A Brain Tumor

August 23rd 2020, 2:00pm


After receiving a stage 4 glioblastoma diagnosis, one woman taps into her sense of humor — and turns that into a book.